The application of stomatological biofilms containing clindamycin and galavit for the combined treatment of chronic generalized periodontitis

Abstract


Stomatological biofilms Diplen K and Diplen G were used to treat patients presenting with chronic generalized periodontitis. The most characteristic general and local features of this pathological condition associated with type 1 periodontopathogenic bacteria were identified. It was shown that Diplen biofilms applied in combination with antibiotics clindamycin and immunomodulator galavit substantially suppress inflammatory reactions; moreover, they appear to reduce alteration of periodontal tissues. At the same time, clindamycin slows down the development and invasion of microorganisms which leads to a significant decrease in the number of the most aggressive anaerobic bacteria or their complete elimination; also, it strengthens the positive effect of the combined treatment. The patients reported the improvement of the overall health and needed no additional therapy.

References

  1. Подколзин А. А., Гришина Т. И. (ред.). Галавит: Клиническое использование и механизмы действия // Сб. науч. трудов. - М., 2002. - С. 55-62.
  2. Царев В. Н., Ушаков Р. В., Плахтий Л. Я., Чухаджян Г. Ф. Применение адгезивных пленок "Диплен-дента" в комплексном лечении пародонтита: Метод. рекомендации. - М., 2002.
  3. Царев В. Н., Николаева Е. Н. // Стоматология. - 2007. - № 5. - С. 82-87.
  4. Чергештов Ю. И., Минин Е. В., Царева Т. В., Артемова В. О. // Стоматолог. - 2009. - № 5-6. - С. 28-39.
  5. Янушевич О. О., Ушаков Р. В., Царев В. Н. Антимикробная терапия и профилактика осложнений воспалительных заболеваний пародонта: Учеб. пособие. - М., 2009
  6. Chapple I. L. C. // Periodontology. - 2009. - Vol. 51, N 1. - P. 9-24.
  7. Ellison S. J. // Br. Dent. J. - 2009. - Vol. 206, N 7. - P. 357-362.

Statistics

Views

Abstract - 25

Cited-By


Article Metrics

Metrics Loading ...

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies